洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-TRC-12002644】External cephalic version for breech presentation: A randomised controlled trial of anaesthetic interventions

基本信息
登记号

ChiCTR-TRC-12002644

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2012-11-04

临床申请受理号

/

靶点

/

适应症

Breech Presentation during Pregnancy

试验通俗题目

External cephalic version for breech presentation: A randomised controlled trial of anaesthetic interventions

试验专业题目

External cephalic version for breech presentation: A randomised controlled trial of anaesthetic interventions

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

Our objectives in this prospective randomised blinded control study are to compare the outcome and effects of using (A) intravenous analgesia or (B) spinal anaesthesia for primary and reattempts of ECV at term. Secondary objectives are comparisons of the effects on the fetus, mechanical forces used, pain and side effects during ECV. The conclusion will define the role of using IV analgesia and spinal anaesthesia for ECV, and establish guidelines that are not available in current literature.

试验分类
试验类型

随机平行对照

试验分期

其它

随机化

Random Shuffled coded envelope

盲法

/

试验项目经费来源

Research Grants Council of Hong Kong

试验范围

/

目标入组人数

63

实际入组人数

/

第一例入组时间

2003-05-01

试验终止时间

2008-10-01

是否属于一致性

/

入选标准

All singleton pregnancies suitable to have ECV for breech presentation at or beyond 36 weeks of gestation will be assessed for eligibility for inclusion. 24;25;27;40 ECVs for transverse lie, unstable lie, or second twin will be excluded for the purpose of this study. Patients suitable for this study would be in good health (ASA 1-2), and those contraindicated to have spinal anaesthesia or IV analgesia will be excluded. Informed written consent will obtained from all patients, before commencement of study.;

排除标准

NA;

研究者信息
研究负责人姓名
试验机构

Research Grants Council of Hong Kong

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品